FDA Approves Cardiac Adhesion Barrier for Pediatric Use
MedSun: Newsletter #36, May 2009

The FDA announced its approval of a device that reduces the severity of adhesions in children undergoing open-heart surgery. Repel-CV is a synthetic film barrier inserted over the heart just before a surgeon closes the chest following an open-heart procedure. During the early healing stages, the temporary, absorbable barrier helps reduce the severity of post-surgical adhesions.

Additional Information:

FDA Approves Cardiac Adhesion Barrier for Pediatric Use. FDA Press Release. March 6, 2009.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149538.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun